OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer (original) (raw)

• Chi, D.S. et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol. Oncol. 82, 532–537 (2001).
  Article CAS Google Scholar
• Hoskins, W.J. Prospective on ovarian cancer: why prevent? J. Cell. Biochem. Suppl. 23, 189–199 (1995).
• Auersperg, N., Wong, A.S., Choi, K.C., Kang, S.K. & Leung, P.C. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr. Rev. 22, 255–288 (2001).
  CAS PubMed Google Scholar
• Thiagalingam, S. et al. Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr. Opin. Oncol. 14, 65–72 (2002).
  Article CAS Google Scholar
• Davis, M., Hitchcock, A., Foulkes, W.D. & Campbell, I.G. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res. 56, 741–744 (1996).
  CAS PubMed Google Scholar
• Gabra, H. et al. Definition and refinement of a region of loss of heterozygosity at 11q23.3–q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res. 56, 950–954 (1996).
  CAS PubMed Google Scholar
• Gabra, H. et al. Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. Br. J. Cancer 72, 367–375 (1995).
  Article CAS Google Scholar
• Foulkes, W.D., Campbell, I.G., Stamp, G.W. & Trowsdale, J. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br. J. Cancer 67, 268–273 (1993).
  Article CAS Google Scholar
• Launonen, V. et al. Chromosome 11q22.3–q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions. Gynecol. Oncol. 71, 299–304 (1998).
  Article CAS Google Scholar
• Jones, P.A. & Laird, P.W. Cancer epigenetics comes of age. Nat. Genet. 21, 163–167 (1999).
  Article CAS Google Scholar
• Shark, K.B. & Lee, N.M. Cloning, sequencing and localization to chromosome 11 of a cDNA encoding a human opioid-binding cell adhesion molecule (OBCAM). Gene 155, 213–217 (1995).
  Article CAS Google Scholar
• Harpaz, Y. & Chothia, C. Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains. J. Mol. Biol. 238, 528–539 (1994).
  Article CAS Google Scholar
• Wilson, D.J., Kim, D.S., Clarke, G.A., Marshall-Clarke, S. & Moss, D.J. A family of glycoproteins (GP55), which inhibit neurite outgrowth, are members of the Ig superfamily and are related to OBCAM, neurotrimin, LAMP and CEPU-1. J. Cell Sci. 109, 3129–3138 (1996).
  CAS PubMed Google Scholar
• Gil, O.D., Zanazzi, G., Struyk, A.F. & Salzer, J.L. Neurotrimin mediates bifunctional effects on neurite outgrowth via homophilic and heterophilic interactions. J. Neurosci. 18, 9312–9325 (1998).
  Article CAS Google Scholar
• Funatsu, N. et al. Characterization of a novel rat brain glycosylphosphatidylinositol-anchored protein (Kilon), a member of the IgLON cell adhesion molecule family. J. Biol. Chem. 274, 8224–8230 (1999).
  Article CAS Google Scholar
• Hachisuka, A., Nakajima, O., Yamazaki, T. & Sawada, J. Developmental expression of opioid-binding cell adhesion molecule (OBCAM) in rat brain. Brain Res. Dev. Brain Res. 122, 183–191 (2000).
  Article CAS Google Scholar
• Lodge, A.P., Howard, M.R., McNamee, C.J. & Moss, D.J. Co-localisation, heterophilic interactions and regulated expression of IgLON family proteins in the chick nervous system. Brain Res. Mol. Brain Res. 82, 84–94 (2000).
  Article CAS Google Scholar
• Miyata, S. et al. Expression of the IgLON cell adhesion molecules Kilon and OBCAM in hypothalamic magnocellular neurons. J. Comp. Neurol. 424, 74–85 (2000).
  Article CAS Google Scholar
• Rai, S.K. et al. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc. Natl. Acad. Sci. USA 98, 4443–4448 (2001).
  Article CAS Google Scholar
• Ji, L. et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res. 62, 2715–2720 (2002).
  CAS PubMed PubMed Central Google Scholar
• Haber, D. & Harlow, E. Tumour-suppressor genes: evolving definitions in the genomic age. Nat. Genet. 16, 320–322 (1997).
  Article CAS Google Scholar
• Ponder, B.A. Cancer genetics. Nature 411, 336–341 (2001).
  Article CAS Google Scholar
• Balmain, A. Cancer: new-age tumour suppressors. Nature 417, 235–237 (2002).
  Article CAS Google Scholar
• Li, Q.L. et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109, 113–124 (2002).
  Article CAS Google Scholar
• Sellar, G.C. et al. BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression. Cancer Res. 61, 6977–6981 (2001).
  CAS PubMed Google Scholar
• Axton, R.A. et al. Combined SSCP/heteroduplex analysis in the screening for PAX6 mutations. Mol. Cell. Probes 11, 287–292 (1997).
  Article CAS Google Scholar
• Thompson, J.D., Higgins, D.G. & Gibson, T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673–4680 (1994).
  Article CAS Google Scholar
• Altschul, S.F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389–3402 (1997).
  Article CAS Google Scholar
• Freigang, J. et al. The crystal structure of the ligand binding module of axonin-1/TAG-1 suggests a zipper mechanism for neural cell adhesion. Cell 101, 425–433 (2000).
  Article CAS Google Scholar
• Bates, P.A., Kelley, L.A., MacCallum, R.M. & Sternberg, M.J. Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins 45 Suppl. 5, 39–46 (2001).
  Article Google Scholar